Literature DB >> 14657279

FAK promotes organization of fibronectin matrix and fibrillar adhesions.

Dusko Ilić1, Branka Kovacic, Kohei Johkura, David D Schlaepfer, Nenad Tomasević, Qin Han, Jae-Beom Kim, Kyle Howerton, Clark Baumbusch, Naoko Ogiwara, Daniel N Streblow, Jay A Nelson, Paul Dazin, Yuji Shino, Katsunori Sasaki, Caroline H Damsky.   

Abstract

Targeted disruption of the focal adhesion kinase (FAK) gene in mice is lethal at embryonic day 8.5 (E8.5). Vascular defects in FAK-/- mice result from the inability of FAK-deficient endothelial cells to organize themselves into vascular network. We found that, although fibronectin (FN) levels were similar, its organization was less fibrillar in both FAK-/- endothelial cells and mesoderm of E8.5 FAK-/- embryos, as well as in mouse embryonic fibroblasts isolated from mutant embryos. FAK catalytic activity, proline-rich domains, and location in focal contacts were all required for proper allocation and patterning of FN matrix. Cells lacking FAK in focal adhesions fail to translocate supramolecular complexes of integrin-bound FN and focal adhesion proteins along actin filaments to form mature fibrillar adhesions. Taken together, our data suggest that proper FN allocation and organization are dependent on FAK-mediated remodeling of focal adhesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657279     DOI: 10.1242/jcs.00845

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  42 in total

1.  Role of focal adhesion kinase (FAK) in renal ischaemia and reperfusion.

Authors:  Konstantin Holzapfel; Wolfgang Neuhofer; Helmut Bartels; Maria-Luisa Fraek; Franz-Xaver Beck
Journal:  Pflugers Arch       Date:  2007-06-05       Impact factor: 3.657

2.  DPP in the matrix mediates cell adhesion but is not restricted to stickiness: a tale of signaling.

Authors:  Asha Eapen; Amsaveni Ramachandran; Anne George
Journal:  Cell Adh Migr       Date:  2012-05-16       Impact factor: 3.405

Review 3.  The coordination between actin filaments and adhesion in mesenchymal migration.

Authors:  Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2009-10-08       Impact factor: 3.405

4.  Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.

Authors:  Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Regulation of matrix assembly through rigidity-dependent fibronectin conformational changes.

Authors:  Cara L Carraher; Jean E Schwarzbauer
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

6.  Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.

Authors:  L Wu; J A Bernard-Trifilo; Y Lim; S-T Lim; S K Mitra; S Uryu; M Chen; C J Pallen; N-Kv Cheung; D Mikolon; A Mielgo; D G Stupack; D D Schlaepfer
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

7.  pVHL function is essential for endothelial extracellular matrix deposition.

Authors:  Nan Tang; Fiona Mack; Volker H Haase; M Celeste Simon; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response.

Authors:  Anna I Markowska; Fu-Tong Liu; Noorjahan Panjwani
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

9.  FRNK expression promotes smooth muscle cell maturation during vascular development and after vascular injury.

Authors:  Rebecca L Sayers; Liisa J Sundberg-Smith; Mauricio Rojas; Haruko Hayasaka; J Thomas Parsons; Christopher P Mack; Joan M Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-11       Impact factor: 8.311

10.  Activation of the integrins alpha 5beta 1 and alpha v beta 3 and focal adhesion kinase (FAK) during arteriogenesis.

Authors:  Wei-Jun Cai; Ming Bo Li; Xiaoqiong Wu; Song Wu; Wu Zhu; Dan Chen; Mingying Luo; Inka Eitenmüller; Andreas Kampmann; Jutta Schaper; Wolfgang Schaper
Journal:  Mol Cell Biochem       Date:  2008-11-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.